BR112022023904A2 - Anticorpos de coelho para imunoglobulinas g humanas - Google Patents

Anticorpos de coelho para imunoglobulinas g humanas

Info

Publication number
BR112022023904A2
BR112022023904A2 BR112022023904A BR112022023904A BR112022023904A2 BR 112022023904 A2 BR112022023904 A2 BR 112022023904A2 BR 112022023904 A BR112022023904 A BR 112022023904A BR 112022023904 A BR112022023904 A BR 112022023904A BR 112022023904 A2 BR112022023904 A2 BR 112022023904A2
Authority
BR
Brazil
Prior art keywords
human immunoglobulin
rabbit antibodies
antibodies
human
rabbit
Prior art date
Application number
BR112022023904A
Other languages
English (en)
Inventor
Chu Ruiyin
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of BR112022023904A2 publication Critical patent/BR112022023904A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ANTICORPOS DE COELHO PARA IMUNOGLOBULINAS G HUMANAS. A presente invenção refere-se a anticorpos de IgG anti-humanos e suas partes de ligação ao antígeno derivados de coelhos e métodos de uso desses anticorpos e partes.
BR112022023904A 2020-06-01 2021-06-01 Anticorpos de coelho para imunoglobulinas g humanas BR112022023904A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063033073P 2020-06-01 2020-06-01
PCT/US2021/035264 WO2021247588A2 (en) 2020-06-01 2021-06-01 Rabbit antibodies to human immunoglobulins g

Publications (1)

Publication Number Publication Date
BR112022023904A2 true BR112022023904A2 (pt) 2022-12-27

Family

ID=76859716

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022023904A BR112022023904A2 (pt) 2020-06-01 2021-06-01 Anticorpos de coelho para imunoglobulinas g humanas

Country Status (14)

Country Link
US (1) US20210380719A1 (pt)
EP (1) EP4157870A2 (pt)
JP (1) JP2023532412A (pt)
KR (1) KR20230018478A (pt)
CN (1) CN115698061A (pt)
AR (1) AR122498A1 (pt)
AU (1) AU2021283192A1 (pt)
BR (1) BR112022023904A2 (pt)
CA (1) CA3184763A1 (pt)
CO (1) CO2022019089A2 (pt)
IL (1) IL298621A (pt)
MX (1) MX2022015236A (pt)
TW (1) TW202210525A (pt)
WO (1) WO2021247588A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115819578B (zh) * 2022-10-29 2023-08-18 武汉爱博泰克生物科技有限公司 高亲和力Human IL-5兔单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142374A1 (en) 1998-08-17 2002-10-03 Michael Gallo Generation of modified molecules with increased serum half-lives
WO2011137388A2 (en) * 2010-04-30 2011-11-03 Fred Hutchinson Cancer Research Center Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample

Also Published As

Publication number Publication date
CA3184763A1 (en) 2021-12-09
EP4157870A2 (en) 2023-04-05
AR122498A1 (es) 2022-09-14
TW202210525A (zh) 2022-03-16
WO2021247588A3 (en) 2022-02-17
CO2022019089A2 (es) 2022-12-30
JP2023532412A (ja) 2023-07-28
WO2021247588A2 (en) 2021-12-09
CN115698061A (zh) 2023-02-03
KR20230018478A (ko) 2023-02-07
US20210380719A1 (en) 2021-12-09
AU2021283192A1 (en) 2023-02-09
MX2022015236A (es) 2023-01-11
IL298621A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
CO2020014773A2 (es) Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación
BR112021012027A2 (pt) Molécula bifuncional direcionada contra pd-1 humano
BR112018012113A2 (pt) anticorpos monoclonais de ctla4 anti-humana quiméricos e humanizados e usos dos mesmo
CR11030A (es) Proteinas de union, incluyendo anticuerpos, derivados de anticuerpos y fragmentos de anticuerpos, que se unen especificamente a cd154 y sus usos
RU2011148913A (ru) Иммуноглобулин с двумя вариабельными доменами и его применение
EA201891582A1 (ru) Иммуностимулирующие гуманизированные моноклональные антитела против интерлейкина-2 человека и их слитые белки
EA201391159A1 (ru) Hla-рестриктированные пептидоспецифические антигенсвязывающие белки
CR20120027A (es) Polipeptidos y metodo de tratamiento
WO2008097817A3 (en) Multivariable antigens complexed with targeting humanized monoclonal antibody
CR20210628A (es) Fragmentos de unión al antígeno cd3 y composiciones que comprenden los mismos
RU2018137110A (ru) Антитела против psma и их применение
BR112022023904A2 (pt) Anticorpos de coelho para imunoglobulinas g humanas
MX2020013606A (es) Constructos de anticuerpos multiespecificos.
IL307417A (en) A chimeric antigen receptor comprising an anti-HER2 antibody or an antigen-binding fragment thereof and natural killer cells comprising the same
BR112023025433A2 (pt) Anticorpos anti-ccr8 e seus usos
PE20231504A1 (es) Anticuerpos especificos para kras y sus usos
EP3889180A4 (en) ANTI-OX40 HUMANIZED MONOCLONAL ANTIBODY, METHOD FOR PREPARATION AND USE
WO2002092136A3 (de) Immunkonjugate aus eidotter-antikörpern (igy), deren konfektionierung und anwendung in diagnostik und therapie
EP4153635A4 (en) ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME
MX2023008028A (es) Anticuerpos anti-pd-l1 y proteinas de fusion de estos.
BR112022004570A2 (pt) Terapia de combinação com anticorpos entpd2 e cd73
GB202218296D0 (en) Anti-ctla4 monoclonal antibodies and chimeric antigen receptors
EA202090581A1 (ru) Продукты слияния транстиретина и иммуноглобулина
EP3858855A4 (en) HUMANIZED MONOCLONAL ANTI-HUMAN CTLA4 ANTIBODY, METHOD OF PRODUCTION THEREOF AND USE THEREOF
EP3778645A4 (en) MONOCLONAL ANTIBODIES SPECIFICALLY RESPONDING TO NCC-ST-439 ANTIGEN AND METHOD FOR MANUFACTURING IT